591 related articles for article (PubMed ID: 8946930)
21. FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemia.
Galimberti S; Rossi A; Palumbo GA; Morabito F; Guerrini F; Vincelli I; Fazzi R; Santini V; Petrini M
Anticancer Res; 2003; 23(4):3419-26. PubMed ID: 12926083
[TBL] [Abstract][Full Text] [Related]
22. Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type.
Chen W; Jones D; Medeiros LJ; Luthra R; Lin P
Br J Haematol; 2005 Sep; 130(5):726-8. PubMed ID: 16115128
[TBL] [Abstract][Full Text] [Related]
23. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance].
Wang YG; Liu XH; Liang Y; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):741-5. PubMed ID: 19176010
[TBL] [Abstract][Full Text] [Related]
24. FLT3 mutations in acute myeloid leukemia cell lines.
Quentmeier H; Reinhardt J; Zaborski M; Drexler HG
Leukemia; 2003 Jan; 17(1):120-4. PubMed ID: 12529668
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor.
Tse KF; Allebach J; Levis M; Smith BD; Bohmer FD; Small D
Leukemia; 2002 Oct; 16(10):2027-36. PubMed ID: 12357354
[TBL] [Abstract][Full Text] [Related]
26. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC
Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077
[TBL] [Abstract][Full Text] [Related]
27. Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia.
Moreno I; Martín G; Bolufer P; Barragán E; Rueda E; Román J; Fernández P; León P; Mena A; Cervera J; Torres A; Sanz MA
Haematologica; 2003 Jan; 88(1):19-24. PubMed ID: 12551822
[TBL] [Abstract][Full Text] [Related]
28. Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype.
Neben K; Schnittger S; Brors B; Tews B; Kokocinski F; Haferlach T; Müller J; Hahn M; Hiddemann W; Eils R; Lichter P; Schoch C
Oncogene; 2005 Feb; 24(9):1580-8. PubMed ID: 15674343
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia.
Kondo M; Horibe K; Takahashi Y; Matsumoto K; Fukuda M; Inaba J; Kato K; Kojima S; Matsuyama T
Med Pediatr Oncol; 1999 Dec; 33(6):525-9. PubMed ID: 10573574
[TBL] [Abstract][Full Text] [Related]
30. Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia.
Horiike S; Yokota S; Nakao M; Iwai T; Sasai Y; Kaneko H; Taniwaki M; Kashima K; Fujii H; Abe T; Misawa S
Leukemia; 1997 Sep; 11(9):1442-6. PubMed ID: 9305595
[TBL] [Abstract][Full Text] [Related]
31. FMS-like tyrosine kinase 3 internal tandem duplication and the patterns of its gene sequence in 207 Chinese patients with de novo acute myeloid leukemia.
Zhong L; Jia YQ; Meng WT; Ni X
Arch Pathol Lab Med; 2012 Jan; 136(1):84-9. PubMed ID: 22208491
[TBL] [Abstract][Full Text] [Related]
32. AML1B transcriptional repressor function is impaired by the Flt3-internal tandem duplication.
Takahashi S; Harigae H; Kameoka J; Sasaki T; Kaku M
Br J Haematol; 2005 Aug; 130(3):428-36. PubMed ID: 16042694
[TBL] [Abstract][Full Text] [Related]
33. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
34. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain.
Kiyoi H; Ohno R; Ueda R; Saito H; Naoe T
Oncogene; 2002 Apr; 21(16):2555-63. PubMed ID: 11971190
[TBL] [Abstract][Full Text] [Related]
36. Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia.
Choi Y; Kim HJ; Park BH; Min WS; Kim CC
Leukemia; 2005 Jan; 19(1):141-3. PubMed ID: 15510198
[No Abstract] [Full Text] [Related]
37. Detection of FLT3 gene and FLT3/ITD mutation by polymerase chain reaction-single-strand conformation polymorphism in patients with acute lymphoblastic leukemia.
Xu B; Li L; Tang JH; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1207-10. PubMed ID: 16234090
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis.
Yanada M; Matsuo K; Suzuki T; Kiyoi H; Naoe T
Leukemia; 2005 Aug; 19(8):1345-9. PubMed ID: 15959528
[TBL] [Abstract][Full Text] [Related]
39. RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.
Side LE; Curtiss NP; Teel K; Kratz C; Wang PW; Larson RA; Le Beau MM; Shannon KM
Genes Chromosomes Cancer; 2004 Mar; 39(3):217-23. PubMed ID: 14732923
[TBL] [Abstract][Full Text] [Related]
40. Loss of DCC gene expression is of prognostic importance in acute myelogenous leukemia.
Inokuchi K; Yamaguchi H; Hanawa H; Tanosaki S; Nakamura K; Tarusawa M; Miyake K; Shimada T; Dan K
Clin Cancer Res; 2002 Jun; 8(6):1882-8. PubMed ID: 12060632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
